e-Article
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update.
Document Type
Article
Author
Smith, Catherine H; Yiu, Zenas Z N; Bale, Tracy; Burden, A David; Coates, Laura C; Eckert, Elizabeth; Longley, Nicky; Mahil, Satveer K; McGuire, Arlene; Murphy, Ruth; Nelson-Piercy, Catherine; Owen, Caroline M; Parslew, Richard; Woolf, Richard T; Kiaee, Zahra Mansour; Constantin, Alina M; Ezejimofor, Martinsixtus C; Exton, Lesley S; Mustapa, M Firouz Mohd
Source
Subject
*BIOTHERAPY
*PSORIASIS
*DERMATOLOGISTS
*HEART failure
*YOUNG adults
*
*
*
*
Language
ISSN
0007-0963
Abstract
The British Association of Dermatologists (BAD) has updated its clinical guideline for biologic therapy for psoriasis, including new treatments approved since the previous version. The guideline will now be a living guideline, updated as new evidence emerges. The decision aid for clinicians and patients has also been updated. The document provides information on different biologic treatments for psoriatic arthritis, including medication details, dosing frequency, approval dates, success rates, and potential side effects. It emphasizes that some treatments are recommended only after other options have failed and not all treatments are approved for psoriatic arthritis. The document is based on real-world data and aims to support clinical practice. [Extracted from the article]